
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $844.1M | $896.6M | $911.3M | $960.9M | $1B | |
Revenue Growth (YoY) | 8.41% | 6.22% | 1.64% | 5.44% | 7.5% | |
Cost of Revenues | $350.5M | $381.3M | $423.8M | $457.2M | $488.6M | |
Gross Profit | $493.6M | $515.3M | $487.5M | $503.7M | $544.4M | |
Gross Profit Margin | 58.47% | 57.48% | 53.5% | 52.42% | 52.7% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $207.7M | $224.7M | $241.6M | $246M | $258.7M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$1.9M | |
Operating Expenses | $216.1M | $233.1M | $250M | $254.5M | $267.1M | |
Operating Income | $277.4M | $282.2M | $237.5M | $249.3M | $277.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $333.1M | $331.3M | $240.1M | $259.7M | $291.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $75.9M | $70.9M | $55.4M | $54.7M | $65.1M | |
Net Income to Company | $257.2M | $260.3M | $184.7M | $205M | $226.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $257.2M | $260.3M | $184.7M | $205M | $226.2M | |
Basic EPS (Cont. Ops) | $5.49 | $5.94 | $5.75 | $6.83 | $7.77 | |
Diluted EPS (Cont. Ops) | $5.45 | $5.92 | $5.73 | $6.80 | $7.73 | |
Weighted Average Basic Share | $46.9M | $43.8M | $32.1M | $30M | $29.1M | |
Weighted Average Diluted Share | $47.2M | $44M | $32.2M | $30.1M | $29.3M | |
EBITDA | $367.2M | $365.3M | $271.3M | $291.7M | $327.9M | |
EBIT | $337.5M | $334.9M | $240.1M | $259.7M | $291.3M | |
Revenue (Reported) | $844.1M | $896.6M | $911.3M | $960.9M | $1B | |
Operating Income (Reported) | $277.4M | $282.2M | $237.5M | $249.3M | $277.3M | |
Operating Income (Adjusted) | $337.5M | $334.9M | $240.1M | $259.7M | $291.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $236.9M | $244.1M | $250.1M | $274.7M | $289.3M | |
Revenue Growth (YoY) | 6.89% | 3.04% | 2.45% | 9.82% | 5.33% | |
Cost of Revenues | $93.3M | $103.8M | $110.9M | $122M | $128.5M | |
Gross Profit | $143.6M | $140.3M | $139.3M | $152.7M | $160.8M | |
Gross Profit Margin | 60.63% | 57.47% | 55.68% | 55.58% | 55.59% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $57.3M | $60.7M | $62.7M | $66.1M | $70.7M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $59.4M | $62.8M | $64.8M | $68.2M | $72.8M | |
Operating Income | $84.2M | $77.5M | $74.5M | $84.5M | $88M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $98.1M | $77.7M | $76.6M | $88.2M | $91.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $20M | $19.6M | $17M | $20.2M | $19.8M | |
Net Income to Company | $78.1M | $58.1M | $59.6M | $68M | $71.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $78.1M | $58.1M | $59.6M | $68M | $71.6M | |
Basic EPS (Cont. Ops) | $1.70 | $1.67 | $1.96 | $2.31 | $2.53 | |
Diluted EPS (Cont. Ops) | $1.69 | $1.66 | $1.94 | $2.29 | $2.52 | |
Weighted Average Basic Share | $46.1M | $34.8M | $30.5M | $29.5M | $28.3M | |
Weighted Average Diluted Share | $46.3M | $34.9M | $30.6M | $29.6M | $28.5M | |
EBITDA | $106.4M | $85.5M | $84.3M | $97M | $101M | |
EBIT | $98.9M | $77.7M | $76.6M | $88.2M | $91.4M | |
Revenue (Reported) | $236.9M | $244.1M | $250.1M | $274.7M | $289.3M | |
Operating Income (Reported) | $84.2M | $77.5M | $74.5M | $84.5M | $88M | |
Operating Income (Adjusted) | $98.9M | $77.7M | $76.6M | $88.2M | $91.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $859.4M | $903.8M | $917.3M | $985.4M | $1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $357.3M | $391.8M | $430.8M | $468.3M | $495M | |
Gross Profit | $502M | $512M | $486.5M | $517.1M | $552.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $212.7M | $228.1M | $243.5M | $249.4M | $263.3M | |
Other Inc / (Exp) | $396K | -- | -- | -- | -- | |
Operating Expenses | $221.2M | $236.5M | $251.9M | $257.9M | $271.8M | |
Operating Income | $280.9M | $275.4M | $234.5M | $259.3M | $280.8M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $337.1M | $310.9M | $239.1M | $271.3M | $294.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $73.1M | $70.6M | $52.9M | $57.8M | $64.7M | |
Net Income to Company | $263.9M | $240.3M | $186.2M | $213.4M | $229.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $263.9M | $240.3M | $186.2M | $213.4M | $229.8M | |
Basic EPS (Cont. Ops) | $5.68 | $5.99 | $6.04 | $7.18 | $8.01 | |
Diluted EPS (Cont. Ops) | $5.66 | $5.98 | $6.00 | $7.14 | $7.97 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $370.8M | $344.4M | $270.1M | $304.4M | $331.9M | |
EBIT | $340.7M | $313.7M | $239.1M | $271.3M | $294.5M | |
Revenue (Reported) | $859.4M | $903.8M | $917.3M | $985.4M | $1B | |
Operating Income (Reported) | $280.9M | $275.4M | $234.5M | $259.3M | $280.8M | |
Operating Income (Adjusted) | $340.7M | $313.7M | $239.1M | $271.3M | $294.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $236.9M | $244.1M | $250.1M | $274.7M | $289.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $93.3M | $103.8M | $110.9M | $122M | $128.5M | |
Gross Profit | $143.6M | $140.3M | $139.3M | $152.7M | $160.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $57.3M | $60.7M | $62.7M | $66.1M | $70.7M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $59.4M | $62.8M | $64.8M | $68.2M | $72.8M | |
Operating Income | $84.2M | $77.5M | $74.5M | $84.5M | $88M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $98.1M | $77.7M | $76.6M | $88.2M | $91.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $20M | $19.6M | $17M | $20.2M | $19.8M | |
Net Income to Company | $78.1M | $58.1M | $59.6M | $68M | $71.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $78.1M | $58.1M | $59.6M | $68M | $71.6M | |
Basic EPS (Cont. Ops) | $1.70 | $1.67 | $1.96 | $2.31 | $2.53 | |
Diluted EPS (Cont. Ops) | $1.69 | $1.66 | $1.94 | $2.29 | $2.52 | |
Weighted Average Basic Share | $46.1M | $34.8M | $30.5M | $29.5M | $28.3M | |
Weighted Average Diluted Share | $46.3M | $34.9M | $30.6M | $29.6M | $28.5M | |
EBITDA | $106.4M | $85.5M | $84.3M | $97M | $101M | |
EBIT | $98.9M | $77.7M | $76.6M | $88.2M | $91.4M | |
Revenue (Reported) | $236.9M | $244.1M | $250.1M | $274.7M | $289.3M | |
Operating Income (Reported) | $84.2M | $77.5M | $74.5M | $84.5M | $88M | |
Operating Income (Adjusted) | $98.9M | $77.7M | $76.6M | $88.2M | $91.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $245.8M | $600.9M | $120.4M | $146.5M | $324.6M | |
Short Term Investments | $10.8M | -- | $61.3M | $98M | -- | |
Accounts Receivable, Net | $62.2M | $70.1M | $77.4M | $78.8M | $82.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $8.6M | $8.8M | $11.4M | $12.9M | $11.9M | |
Total Current Assets | $333.7M | $681M | $273.3M | $337.5M | $420M | |
Property Plant And Equipment | $189.7M | $193.8M | $220.2M | $262.2M | $276.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $160.8M | $160.8M | $160.8M | $160.8M | $160.8M | |
Other Intangibles | $193.6M | $185.2M | $176.8M | $168.4M | $160M | |
Other Long-Term Assets | $1.8M | $1.9M | $1.7M | $1.6M | $1.4M | |
Total Assets | $1.8B | $1.2B | $832.7M | $930.5M | $1B | |
Accounts Payable | $16.6M | $24.3M | $20M | $17.7M | $26.7M | |
Accrued Expenses | $21.9M | $27.6M | $22.5M | $26.7M | $29.6M | |
Current Portion Of Long-Term Debt | $33.1M | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $7.4M | $7.4M | $8.6M | $11M | $12.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $118.7M | $97.9M | $99.7M | $97M | $111M | |
Long-Term Debt | $74.6M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $270.3M | $177.7M | $195.1M | $212.4M | $234.6M | |
Common Stock | $533K | $536K | $538K | $540K | $541K | |
Other Common Equity Adj | -- | -- | -$533K | -$57K | -- | |
Common Equity | $1.6B | $1B | $637.6M | $718M | $783.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.6B | $1B | $637.6M | $718M | $783.9M | |
Total Liabilities and Equity | $1.8B | $1.2B | $832.7M | $930.5M | $1B | |
Cash and Short Terms | $256.6M | $600.9M | $181.7M | $244.5M | $324.6M | |
Total Debt | $107.8M | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $225.8M | $201.9M | $105M | $196.2M | $144.5M | |
Short Term Investments | $36.4M | $62.4M | $89.5M | $94.5M | $160.1M | |
Accounts Receivable, Net | $91.8M | $102M | $102.6M | $111.7M | $115.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $14.5M | $14M | $15.8M | $16.5M | $16.1M | |
Total Current Assets | $374.3M | $380.4M | $315.9M | $444.5M | $436.4M | |
Property Plant And Equipment | $191.4M | $192.3M | $220.7M | $262.3M | $273.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $160.8M | $160.8M | $160.8M | $160.8M | $160.8M | |
Other Intangibles | $191.5M | $183.1M | $174.7M | $166.3M | $157.9M | |
Other Long-Term Assets | $2.1M | $1.8M | $2M | $1.8M | $2.6M | |
Total Assets | $1.9B | $918.4M | $874M | $1B | $1B | |
Accounts Payable | $17.2M | $29.6M | $21.8M | $29.8M | $24.1M | |
Accrued Expenses | $29.5M | $30.7M | $31.7M | $57.6M | $34.6M | |
Current Portion Of Long-Term Debt | $33.1M | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $7.5M | $7.5M | $8.8M | $11.3M | $13.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $152.8M | $132.7M | $119.7M | $160.1M | $128.2M | |
Long-Term Debt | $66.3M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $296.3M | $211.9M | $214.8M | $276.1M | $250.7M | |
Common Stock | $536K | $538K | $540K | $541K | $542K | |
Other Common Equity Adj | -$120K | -$323K | -$414K | -$113K | -$7K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.6B | $706.4M | $659.3M | $759.4M | $780.7M | |
Total Liabilities and Equity | $1.9B | $918.4M | $874M | $1B | $1B | |
Cash and Short Terms | $262.3M | $264.3M | $194.5M | $290.7M | $304.7M | |
Total Debt | $99.5M | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $257.2M | $260.3M | $184.7M | $205M | $226.2M | |
Depreciation & Amoritzation | $29.7M | $30.4M | $31.2M | $32M | $36.6M | |
Stock-Based Compensation | $10.7M | $11.5M | $12.6M | $13.2M | $14.2M | |
Change in Accounts Receivable | -$13.3M | -$2.9M | -$7.4M | -$1.4M | -$4.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $308.8M | $313.1M | $220.8M | $243.7M | $290M | |
Capital Expenditures | $29.9M | $29.4M | $35.6M | $45.4M | $37.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$19.4M | $951M | -$97.1M | -$80.5M | $61.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$33.1M | -$107.8M | -- | -- | -- | |
Repurchase of Common Stock | -$134M | -$803.8M | -$604.2M | -$137.1M | -$173.2M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$166.3M | -$908.9M | -$604.2M | -$137.1M | -$173.2M | |
Beginning Cash (CF) | $122.6M | $245.8M | $600.9M | $120.4M | $146.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $123.2M | $355.2M | -$480.5M | $26.1M | $178.1M | |
Ending Cash (CF) | $245.8M | $600.9M | $120.4M | $146.5M | $324.6M | |
Levered Free Cash Flow | $278.9M | $283.7M | $185.2M | $198.2M | $252.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $78.1M | $58.1M | $59.6M | $68M | $71.6M | |
Depreciation & Amoritzation | $7.5M | $7.8M | $7.6M | $8.8M | $9.6M | |
Stock-Based Compensation | $3M | $3.2M | $3.4M | $3.5M | $3.6M | |
Change in Accounts Receivable | -$29.6M | -$31.9M | -$25.2M | -$32.9M | -$32.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $89.8M | $70.3M | $63M | $85M | $67.6M | |
Capital Expenditures | $9M | $6.9M | $8.8M | $9.1M | $9M | |
Cash Acquisitions | -- | -- | -- | -- | -$1M | |
Cash From Investing | -$34.8M | -$69.7M | -$37.1M | -$5.3M | -$169.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$8.3M | -- | -- | -- | -- | |
Repurchase of Common Stock | -$69.3M | -$399.6M | -$41.2M | -$30M | -$77.9M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$74.9M | -$399.6M | -$41.2M | -$30M | -$77.9M | |
Beginning Cash (CF) | $245.8M | $600.9M | $120.4M | $146.5M | $324.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$19.9M | -$399M | -$15.4M | $49.7M | -$180.1M | |
Ending Cash (CF) | $225.8M | $201.9M | $105M | $196.2M | $144.5M | |
Levered Free Cash Flow | $80.8M | $63.4M | $54.2M | $75.9M | $58.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $263.9M | $240.3M | $186.2M | $213.4M | $229.8M | |
Depreciation & Amoritzation | $30.1M | $30.7M | $31M | $33.1M | $37.4M | |
Stock-Based Compensation | $11M | $11.7M | $12.8M | $13.3M | $14.4M | |
Change in Accounts Receivable | -$14.4M | -$5.2M | -$565K | -$9.1M | -$4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $312.9M | $293.6M | $213.6M | $265.6M | $272.6M | |
Capital Expenditures | $32.8M | $27.3M | $37.6M | $45.7M | $37.6M | |
Cash Acquisitions | -- | -- | -- | -- | -$1M | |
Cash From Investing | -$52.3M | $916.1M | -$64.6M | -$48.6M | -$103.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$33.1M | -- | -- | -- | -- | |
Repurchase of Common Stock | -$137.7M | -$1.1B | -$245.9M | -$125.9M | -$221.1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$167.3M | -$1.2B | -$245.9M | -$125.9M | -$221.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $93.3M | -$23.9M | -$96.9M | $91.2M | -$51.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $280.1M | $266.3M | $176M | $220M | $235M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $78.1M | $58.1M | $59.6M | $68M | $71.6M | |
Depreciation & Amoritzation | $7.5M | $7.8M | $7.6M | $8.8M | $9.6M | |
Stock-Based Compensation | $3M | $3.2M | $3.4M | $3.5M | $3.6M | |
Change in Accounts Receivable | -$29.6M | -$31.9M | -$25.2M | -$32.9M | -$32.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $89.8M | $70.3M | $63M | $85M | $67.6M | |
Capital Expenditures | $9M | $6.9M | $8.8M | $9.1M | $9M | |
Cash Acquisitions | -- | -- | -- | -- | -$1M | |
Cash From Investing | -$34.8M | -$69.7M | -$37.1M | -$5.3M | -$169.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$8.3M | -- | -- | -- | -- | |
Repurchase of Common Stock | -$69.3M | -$399.6M | -$41.2M | -$30M | -$77.9M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$74.9M | -$399.6M | -$41.2M | -$30M | -$77.9M | |
Beginning Cash (CF) | $245.8M | $600.9M | $120.4M | $146.5M | $324.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$19.9M | -$399M | -$15.4M | $49.7M | -$180.1M | |
Ending Cash (CF) | $225.8M | $201.9M | $105M | $196.2M | $144.5M | |
Levered Free Cash Flow | $80.8M | $63.4M | $54.2M | $75.9M | $58.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.